Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Clasificación en acciones #40612
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Precio por acción
$0.13607016
Última sincronización: 2024-09-10
Capitalización bursátil
$112.29K
Cambio (1 día)
22.46%
Cambio (1 año)
0.00%
País
GB
Comercio BiVictriX Therapeutics Plc (BVX)

Categoría

Historial del precio de la acción de BiVictriX Therapeutics Plc (BVX)
Precio más alto de cierre: $0.11 el 2024-09-01

Precio más bajo de cierre: $0.30 el 2021-08-01
Historial del precio de la acción de BiVictriX Therapeutics Plc desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 -21.63%
2023 -33.60%
2022 -41.42%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$518.40 30.94%
US
$860.09 33.02%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE